Comparative effectiveness of higher adalimumab maintenance therapy versus standard dose in anti-tumor necrosis factor experienced Crohn's disease patients: A propensity-score matched cohort analysis.
Neeraj NarulaEmily Chu Lee WongRaed AlRamdanHasan BualbanatJohn K MarshallA Hillary SteinhartTomer GreenerMark S SilverbergPublished in: Journal of gastroenterology and hepatology (2021)
High-dose maintenance regimens were associated with longer time-to-failure as compared with SD regimens in CD patient who failed anti-TNF.